Hillburn, NY, United States of America

Gerhard Schlingmann


Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Hilburn, NY (US) (1994)
  • Hillburn, NY (US) (1995 - 1998)

Company Filing History:


Years Active: 1994-1998

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Gerhard Schlingmann: Pioneer in Antibiotic Innovations

Introduction

Gerhard Schlingmann, based in Hillburn, NY (US), is a notable inventor recognized for his contributions to the field of microbiology and antibiotic development. With a total of four patents to his name, Schlingmann has focused his research on isolating and characterizing new antibacterial and antifungal agents derived from fungal cultures.

Latest Patents

Among his notable inventions, one of the latest patents is centered on the isolation, characterization, and structures of new antibiotic components designated as 07F275. This patent discusses novel antibacterial agents produced by fungal culture, detailing methods for fermentation, recovery, and purification from crude solutions. Furthermore, his work on fungicidal agents LL-15G256 reveals new antifungal compounds that offer potential therapeutic applications against fungal infections.

Career Highlights

Gerhard Schlingmann has made significant strides in the pharmaceutical industry, working at the American Cyanamid Company, where his innovative research has contributed to the development of effective antimicrobial agents. His focus on natural compounds represents a growing trend in pharmaceutical research that seeks to discover novel treatments in an era of increasing antibiotic resistance.

Collaborations

Throughout his career, Schlingmann has collaborated with esteemed colleagues, including Stuart A. Rosenfeld and Guy T. Carter. These partnerships have fostered an environment of innovation, contributing to the successful patenting and development of new pharmacological agents that are crucial in the fight against infectious diseases.

Conclusion

Gerhard Schlingmann's work exemplifies the importance of innovation in the fields of microbiology and pharmaceuticals. His patents not only highlight his technical expertise but also his commitment to advancing medical research. With ongoing developments in antibiotic and antifungal agents, Schlingmann’s research continues to pave the way for new treatment options that may improve patient outcomes in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…